INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $632,000 | -22.5% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $816,000 | +9.5% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $745,000 | +6.7% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $698,000 | -41.3% | 20,000 | -2.3% | 0.00% | 0.0% |
Q3 2022 | $1,190,000 | +8.1% | 20,479 | -3.7% | 0.00% | 0.0% |
Q2 2022 | $1,101,000 | -28.7% | 21,272 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $1,545,000 | -38.6% | 21,272 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $2,515,000 | -13.0% | 21,272 | -1.3% | 0.00% | 0.0% |
Q3 2021 | $2,892,000 | -14.2% | 21,559 | +3.5% | 0.00% | -33.3% |
Q2 2021 | $3,372,000 | +96.7% | 20,829 | -2.5% | 0.00% | +50.0% |
Q1 2021 | $1,714,000 | +44.8% | 21,357 | -1.9% | 0.00% | 0.0% |
Q4 2020 | $1,184,000 | +173.4% | 21,773 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $433,000 | -5.3% | 21,773 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $457,000 | +11325.0% | 21,773 | +7157.7% | 0.00% | – |
Q4 2018 | $4,000 | +33.3% | 300 | +200.0% | 0.00% | – |
Q3 2018 | $3,000 | -97.0% | 100 | -97.3% | 0.00% | – |
Q2 2018 | $101,000 | – | 3,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |